MedTrace Logo

18F-FDG PET/CT for IgG4-Related Disease

NCT01665196 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2017-04-07

No results posted yet for this study

Summary

This is an open-label study to investigate the diagnostic performance of 18F-FDG PET/CT (positron emission tomography/computed tomography) in evaluation of patients with IgG4-related disease. A single dose of 18F-FDG will be intravenously injected into patients with IgG4-related disease before and after treatment.

Conditions

Interventions

DRUG

18F-FDG

Intravenous injection of single dose of 18F-FDG before treatment and after 4-week treatment, respectively.

Sponsors & Collaborators

  • Peking Union Medical College Hospital

    lead OTHER

Principal Investigators

  • Wen Zhang, MD · Deptment of Rheumatology, Peking Union Medical College Hospital

  • Fang Li, MD · Department of Nuclear Medicine, Peking Union Medical College Hospital, CAMS & PUMC

  • Zhaohui Zhu, MD · Department of Nuclear Medicine, Peking Union Medical College Hospital

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01665196 on ClinicalTrials.gov